1. Home
  2. Labeler Index
  3. Gland Pharma Limited
  4. 68083-157
  5. NDC Package Code: 68083-157-10 Adenosine

NDC Package 68083-157-10 Adenosine

Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68083-157-10
Package Description:
10 VIAL in 1 CARTON / 4 mL in 1 VIAL
Product Code:
68083-157
Proprietary Name:
Adenosine
Non-Proprietary Name:
Adenosine
Substance Name:
Adenosine
Usage Information:
Intravenous adenosine injection is indicated for the following.Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine injection administration.It is important to be sure the adenosine injection solution actually reaches the systemic circulation (see DOSAGE AND ADMINISTRATION).Adenosine Injection does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. In the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosineinjection administration.
11-Digit NDC Billing Format:
68083015710
NDC to RxNorm Crosswalk:
  • RxCUI: 1654169 - adenosine 6 MG in 2 mL Injection
  • RxCUI: 1654169 - 2 ML adenosine 3 MG/ML Injection
  • RxCUI: 1654169 - adenosine 6 MG per 2 ML Injection
  • RxCUI: 1654186 - adenosine 12 MG in 4 mL Injection
  • RxCUI: 1654186 - 4 ML adenosine 3 MG/ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Gland Pharma Limited
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • ADENOSINE 3 mg/mL
    • Pharmacologic Class(es):
  • Adenosine Receptor Agonist - [EPC] (Established Pharmacologic Class)
  • Adenosine Receptor Agonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA206778
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    01-13-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68083-157-10?

    The NDC Packaged Code 68083-157-10 is assigned to a package of 10 vial in 1 carton / 4 ml in 1 vial of Adenosine, a human prescription drug labeled by Gland Pharma Limited. The product's dosage form is solution and is administered via intravenous form.

    Is NDC 68083-157 included in the NDC Directory?

    Yes, Adenosine with product code 68083-157 is active and included in the NDC Directory. The product was first marketed by Gland Pharma Limited on January 13, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 68083-157-10?

    The 11-digit format is 68083015710. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-268083-157-105-4-268083-0157-10